Skip to Content Facebook Feature Image

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

Business

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine
Business

Business

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

2026-08-17 10:00 Last Updated At:10:15

SINGAPORE, Aug. 17, 2026 /PRNewswire/ -- DayOne Data Centers Limited ("DayOne"), a Singapore-headquartered global digital infrastructure platform, today launched Singapore's first Biological Data Center Prototype in collaboration with Cortical Labs and the Yong Loo Lin School of Medicine, National University of Singapore ("NUS Medicine"). The milestone advances the development of biological computing as a potentially more adaptive and energy-efficient complement to conventional silicon-based infrastructure.

The prototype was launched in the presence of the public sector, representatives from academia, the technology, and digital infrastructure sectors. Delegates viewed a live demonstration of Cortical Labs' CL1 biological computing system and toured the NUS laboratory supporting the initiative.

More Images
DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

The initiative offers a practical, sustainability-aligned alternative to conventional silicon infrastructure in Singapore through wetware-based computing, at a moment when the country and the broader region is expanding AI capacity under tighter energy and environmental guardrails.

The deployment of a 20-unit CL1 biological computing system – the first independently operated biologically integrated server rack in the world – brings Cortical Labs' technology into a live research environment at NUS Medicine, hosted within infrastructure designed and supported by DayOne. It demonstrates an alternative pathway to scale AI capacity with significantly lower power intensity.

A new frontier in computing

Biological computing uses living neurons grown from stem cells and connected to silicon hardware to process information. The neurons receive electrical signals, respond, and adapt over time, enabling the system to perform certain computing tasks on a fraction of the wattage required by digital computers.

The initiative draws on NUS Medicine's neurobiology expertise, Cortical Labs' technology, and DayOne's experience in designing, building, and operating mission-critical digital infrastructure. Areas of exploration include neuro-inspired artificial intelligence, biomedical modelling, drug discovery, and neurological disease research.

"Our commitment to Singapore goes beyond capacity. We are here to help shape what the next generation of digital infrastructure looks like, and that means investing in approaches that meet Singapore's sustainability ambitions alongside its AI ambitions. This prototype is a step toward demonstrating that scaling compute and reducing resource intensity are goals we can pursue together," said Jamie Khoo, Chief Executive Officer of DayOne. "Singapore has the research depth, infrastructure capability, and collaborative ecosystem to lead that exploration. We are proud to contribute to translating frontier scientific research into practical impact, with world-class partners, in one of the world's most sustainability-driven markets."

DayOne operates a digital infrastructure platform across nine markets in Asia Pacific and Europe and has secured approximately 2.1 GW of bookings since inception, supporting the growth of leading cloud and AI customers.

"The establishment of this prototype shifts the conversation from research to commercial application," said Hon Weng Chong, Founder and CEO, Cortical Labs. "Biological computing supplements AI in areas where data is sparse, learning from far less and adapting as conditions change. Our aim is to uncover the use cases where that advantage matters most, in areas such as drug discovery, humanoid robotics, cybersecurity and fraud detection. Ultimately, this is about offering a more sustainable path for the technologies humankind depends on. Singapore is the innovation hub for Asia's data centre industry, and what we build here is the model we intend to replicate and scale globally."

"This partnership marks a genuine shift in how we think about computing and its broader scientific potential," said Professor Rickie Patani, Professor of Neuroscience at NUS Medicine, Director of the Neurobiology Programme at the NUS Life Sciences Institute (LSI) and Chair of the Neuroscience Translational Research Programme at NUS Medicine. "By growing living human neurons from stem cells and pairing them with rigorous engineering, we're not only building a more efficient alternative to silicon; we're creating a platform that can help us understand learning and adaptation at their biological source. That dual promise is what makes this collaboration sustainable and scientifically generative. It gives us a real route to accelerate drug discovery and neurological disease research, turning laboratory insight into real-world impact far faster than we could before."

 

Supporting Singapore's Green Data Center Roadmap

The Biological Data Center Prototype is aligned with Singapore's Green Data Center Roadmap, which sets out higher standards for energy efficiency as the government expands capacity for AI and cloud workloads.

The Prototype forms part of DayOne's broader commitment to Singapore as the headquarters and strategic center of its global platform. The country's combination of research depth, regulatory maturity and collaborative institutional culture creates an environment where few markets can match for responsible frontier computing development.

The initiative is part of DayOne's broader development in Singapore. The company's first local data center SG1 achieved structural topping out in May 2026 and is on track to be operational in early 2027. DayOne is also developing its Global Operations Command Center in Singapore and continues to invest in clean and resilient infrastructure across its regional platform.

About DayOne Data Centers 

DayOne Data Centers Limited ("DayOne") is a Singapore-headquartered global digital infrastructure platform that develops and operates next-generation data centers, with a footprint across markets in Asia Pacific and Europe. Trusted by leading global hyperscalers and enterprises, DayOne designs, builds and operates high-capacity, AI-ready campuses with speed, scale and reliability. Powered by its proprietary integrated delivery model and proven track record of pioneering and scaling new markets, DayOne unlocks strategic capacity to meet accelerating critical infrastructure demands. Established in 2022, DayOne has data center campuses in operation or under development in Singapore, Malaysia, Indonesia, Thailand, Japan, Hong Kong SAR, Finland and Spain. For more information, visit dayonedc.com.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

DayOne Launches Singapore's First Biological Data Center Prototype with Cortical Labs and NUS Medicine

Reusable absorbent hygiene manufacturer Confitex Technology has won the hygiene industry's two top innovation awards, validating washable alternatives to single-use period and incontinence pads and liners – and signaling a more sustainable future for personal hygiene.

AUCKLAND, New Zealand, Sept. 15, 2026 /PRNewswire/ -- Confitex Technology has become the first company to win both of the global nonwovens industry's top awards – the INDEX Award, presented at the INDEX26 expo in Geneva in May 2026, and the Hygienix Innovation Award, presented in the US in November 2025. Its breakthrough washable nonwoven absorbent hygiene products prove that the nonwoven materials used in single-use pads, liners, incontinence guards and bed pads can be stabilised to survive machine washing and tumble drying, and excellent absorbency can be achieved without petroleum-based superabsorbent polymers (SAPs).

Confitex Technology Founder and CEO Frantisek Riha-Scott says the implications are huge. "What Confitex Technology has done is unlock an entirely new product category – washable, reusable absorbent hygiene products that perform as well as, or better than, disposables, at a price point that works for mainstream consumers and mass-market retailers. It's the beginning of a consumer category shift comparable to the move from single-use plastic bags to reusables."

The global absorbent hygiene products (AHP) market is valued at about USD 123.5 billion, with reusable products making up less than 15 percent but growing at a CAGR of 6.89%. EU regulatory pressure supports a move away from single-use plastic products, and the French government recently announced menstrual equity subsidies for reusable period underwear at population scale.

The INDEX Award jury – a panel of global industry experts convened by Brussels-based AHP industry body EDANA – highlighted the market opportunity: "By making absorbent nonwovens fully laundry-compatible, the technology enables nonwoven suppliers to enter the rapidly growing reusable market, historically dominated by textile products. At the same time, the product delivers improved absorbency, leak protection and ease of care for users, while supporting sustainability goals through reusability and the use of predominantly natural-based fibres."

Confitex Technology's award-winning nonwoven reusable pads are up to 90 percent bio-based, contain no SAPS, and have been independently lab-tested by Intertek to match or exceed the absorbency of single-use equivalents. All incoming bulk raw materials are tested for PFAS 'forever chemicals' and all Confitex Technology products meet OEKO-TEX Standard 100 certification.

Confitex Technology Executive Director Lisa Voyle says the company is partnering with global retailers and leading FMCG players to build the washable nonwoven category for mainstream adoption across European and North American markets.

About the awards

The INDEX Awards are presented triennially by Brussels-based nonwovens association EDANA and considered the industry's highest accolade. The Hygienix Innovation Award is presented annually by US-based industry body INDA to honour breakthrough technologies advancing the AHP industry.

About Confitex Technology

Confitex Technology is the tech leader in reusable absorbent hygiene – designing and manufacturing washable absorbent hygiene products (including reusable period pads and liners, period underwear, incontinence underwear, incontinence products, maternity products, pet products, baby products and bed pads) on behalf of private-label retailers, brands and distributors worldwide from its own automated facilities in Asia and Europe. Confitex Technology's innovations are protected by over 60 granted patents and its operations hold ISO 13485, EU Medical Device CE Mark, MDSAP, OEKO-TEX STeP, Good Manufacturing Practice (GMP), Business Social Compliance Initiative (BSCI), Global Organic Textile Standard (GOTS), Recycled Claim Standard (RCS) and FSC Chain of Custody (FSC CoC) certifications.

Read more at confitextechnology.com

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Confitex Technology wins INDEX Award and Hygienix Innovation Award for world-first washable nonwoven absorbent hygiene products

Confitex Technology wins INDEX Award and Hygienix Innovation Award for world-first washable nonwoven absorbent hygiene products

Recommended Articles